Drupal.behaviors.print = function(context) {window.print();window.close();}>
Sequenom Outlicenses Technology for T21 Test, Returns Rights of Separate Patent to TrovaGene
August 17, 2011
Sequenom Outlicenses Technology for T21 Test, Returns Rights of Separate Patent to TrovaGene
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Sequenom Ramps up Hiring, Licenses Additional Technology as it Nears Launch of T21 Test
August 9, 2011 / Clinical Sequencing News
Sequenom Says Competitors Will Have to License IP for Noninvasive T21 Detection Tests
July 27, 2011 / Clinical Sequencing News
Verinata Secures $46.5M for Development, Commercialization of Fetal Trisomy Test
August 9, 2011 / Clinical Sequencing News
As Rivals Vie for Share of Noninvasive Trisomy Testing Market, Physicians See Value for Screening
July 3, 2012 / Clinical Sequencing News
Sequenom Sees Steady Growth of MaterniT21 Test Despite Competition
June 6, 2012 / Clinical Sequencing News